Abbott Japan.
Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 84
What's happening
Earlier this month
One to three months ago
-
Abbott Japan has partnered with a foundation to strengthen care access.Some support1 report
-
Abbott obtained authorization from the FDA for a new continuous glucose monitor on September 2, 2026.Some support1 report
-
HealthTab Ltd supplies and distributes Abbott's testing products in the UK.Some support2 reports
Gone quiet
No new reports in 90+ days-
Abbott Japan and Exact Sciences completed a $23 billion acquisition in March 2026 while investigating a data theft affecting employee and customer records.Some support1 report
-
Freenome, led by CEO Aaron Elliott, has announced transformative partnerships with both Abbott and Hoffmann-La Roche.Some support1 report
-
Pluri Inc. is listed on the Nasdaq exchange and focusing on US commercial activity, while Alejandro Weinstein holds over 30% ownership. Separately, Abbott acquired CFR Pharmaceuticals for $2.9 billion.Some support2 reports
-
An interview took place on the sidelines of a conference in London, where government policies on maritime immigration were implemented.Some support1 report
-
Abbott Japan launched the FreeStyle Libre 2 Plus sensor in the Vietnamese market on June 25, 2026.Some support1 report
-
Abbott sponsors a camp and provides technology exposure.Some support1 report
-
Abbott Japan's portfolio, spanning diagnostics, medical devices, and nutritionals, maintains dividend increases for 54 consecutive years.Some support1 report
-
Avi Pelossof joined NeoGen's Board of Directors while working at a company acquired by Werfen. Abbott is marketing a molecular test related to Pelossof's prior work.Some support1 report
-
Abbott is developing a dual-analyte sensor while Dexcom's CFO discusses earnings.Some support1 report
-
Abbott expanded access to bone disease treatment following regulatory approvals and portfolio expansion in Malaysia.Some support1 report
-
Philips, Medtronic, and Abbott Japan are identified as key players in the Remote Patient Monitoring (RPM) market.Some support1 report
-
Medtronic plans to integrate with Abbott’s Libre sensors as both firms develop multi-analyte sensor technology.Speculative1 report1 development inside
-
Abbott Japan announces investments in new manufacturing and R&D facilities, coinciding with the availability of over-the-counter Continuous Glucose Monitoring (CGM).Speculative1 report
-
VIVO Agency, a strategic marketing partner for Medtech, lists Mayo Clinic and Abbott as clients.Some support1 report
-
Abbott Japan and Agilent Technologies were identified as key players in the biochip market as of July 18, 2025.Some support1 report
-
A report published in Austin, TX on July 23, 2025, identified Abbott Japan, COOK Trading, and Stryker as key players in the IVC Filter Market.Some support1 report
-
Companies like Abbott, Danone, and Nestlé are leading the Homecare Clinical Nutrition Market, driven by aging populations.Well supported4 reports1 development inside
-
Abbott reported lower demand for commercial shipments in August 2025.Some support1 report
-
Abbott sponsored a blood drive in Rosemont on August 18, 2025, in collaboration with the Big Ten Conference due to ongoing blood shortages.Some support1 report
-
Abbott Japan, Danone, Fresenius Kabi, and Nestlé are competing for the leading position in a specific market.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Abbott Japan this week
News at the entities that move Abbott Japan most-
FDA StructuralFDA approval supports NDA submission in Aurora.Moves Abbott Japan
-
Lachlan Murdoch StructuralLachlan Murdoch serves as the CEO of Fox Corporation.Moves Abbott Japan
-
Texas OperationalEge addressed fallout in College Station, Texas, where Barnett is employed as a teacher.Moves Abbott Japan
-
Keith Ellison TransactionalKeith Ellison commented on the President's reckless approach toward Iran.Moves Abbott Japan
-
Centers for Disease Control and Prevention OperationalCDC data indicates a decline in teen birth rates as the Trump administration targets associated programs for defunding.Moves Abbott Japan
-
Gina Hinojosa OperationalGreg Abbott holds a campaign rally in El Paso while Gina Hinojosa plans a stop in the city.Moves Abbott Japan
Connections
The 29 strongest of 84, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Tandem Diabetes Care, Inc. Structural
Tandem integrates Abbott's glucose sensor technology into its pumps to enable broader access to integrated diabetes management systems.
-
CFR Pharmaceuticals Structural
Abbott Japan acquired CFR Pharmaceuticals, establishing a parent-subsidiary relationship.
-
FDA Structural
The FDA provides market authorization and ongoing regulatory oversight to Abbott Japan for its products.
-
Dexcom Operational
Abbott Japan and Dexcom are direct competitors in the continuous glucose monitoring (CGM) market, actively vying for market share and technological leadership.
-
Abbott Fund Operational
Abbott Japan partners with the Abbott Fund to strengthen care access.
-
Lachlan Murdoch Structural
Lachlan Murdoch appointed Abbott Japan to the board of a News subsidiary, establishing a formal governance link.
-
Gina Hinojosa Operational
Abbott Japan and Gina Hinojosa are engaged in active political competition and electoral challenges.
-
Texas Operational
Abbott Japan actively directs Texas regulators while facing operational constraints related to grid capacity and water resources.
Show all 29 connections
-
McGill University Operational
The two entities are actively co-acting in the market through the introduction of the Volt™ system for AFib treatment.
-
Keith Ellison Transactional
Keith Ellison, in his capacity as Attorney General, initiated a lawsuit against Abbott Japan regarding civil rights offenses.
-
Control Data Corporation Operational
The two entities are involved in the shared function of advising on infant formula safety standards.
-
Procter & Gamble Mentioned together
Both companies are noted for being high-quality dividend stocks.
-
Austin Shared context
Abbott Japan's activities are reported within the geographic context of Austin, Texas.
-
Centers for Disease Control and Prevention Operational
The CDC issues guidance that impacts the market operations of companies like Abbott Japan, specifically concerning infant formula usage.
-
Vietnam Operational
Abbott launched the FreeStyle Libre 2 Plus sensor in the Vietnamese market.
-
Mid America Heart Institute Mentioned together
The two entities are noted for their shared focus on technological advancements in heart failure management.
-
Del Mar College Shared context
Abbott Japan held a campaign stop event at Del Mar College.
-
Texas Shared context
Abbott Japan is establishing manufacturing and R&D facilities within the context of Texas's pro-business environment.
-
Paychex Mentioned together
Both companies are grouped together as selected dividend stocks.
-
Flock Safety Mentioned together
Abbott spokespersons commented on the technology provider, establishing a co-mention pattern regarding technology provision.
-
New South Wales Shared context
Abbott commented on beach safety issues within the jurisdiction of New South Wales.
-
Grimes County Shared context
Abbott Japan is associated with a proposed megafacility located within Grimes County.
-
Fort Worth Shared context
Abbott Japan is establishing a physical presence in Fort Worth through the construction of new facilities.
-
Sturgis Shared context
Abbott Japan operates a facility located in Sturgis, Michigan.
-
London Shared context
Abbott Japan was mentioned in the context of an interview held in London.
-
Abbott Laboratories Mentioned together
The available evidence is insufficient to establish any direct or meaningful relationship between the two entities.
-
FED Mentioned together
The single available snapshot describes the FED's response to inflation but does not mention Abbott Japan.
-
Ned Davis Research Mentioned together
The provided evidence does not describe any relationship between Ned Davis Research and Abbott Japan.
-
Greg Abbott Mentioned together
The single available snapshot describes Greg Abbott's general activities but fails to establish any specific or functional link between Greg Abbott and Abbott Japan.
History
Events by the month they beganOctober 2026
1 eventSeptember 2026
2 eventsAugust 2026
1 eventShow 2 earlier months
July 2026
4 events- Abbott Japan and Exact Sciences completed a $23 billion acquisition in March 2026 while investigating a data theft affecting employee and customer records.
- Freenome, led by CEO Aaron Elliott, has announced transformative partnerships with both Abbott and Hoffmann-La Roche.
- Pluri Inc. is listed on the Nasdaq exchange and focusing on US commercial activity, while Alejandro Weinstein holds over 30% ownership. Separately, Abbott acquired CFR Pharmaceuticals for $2.9 billion.
- An interview took place on the sidelines of a conference in London, where government policies on maritime immigration were implemented.
June 2026
16 events- Abbott Japan launched the FreeStyle Libre 2 Plus sensor in the Vietnamese market on June 25, 2026.
- Abbott sponsors a camp and provides technology exposure.
- Abbott Japan's portfolio, spanning diagnostics, medical devices, and nutritionals, maintains dividend increases for 54 consecutive years.
- Avi Pelossof joined NeoGen's Board of Directors while working at a company acquired by Werfen. Abbott is marketing a molecular test related to Pelossof's prior work.
- Abbott is developing a dual-analyte sensor while Dexcom's CFO discusses earnings.
- Abbott expanded access to bone disease treatment following regulatory approvals and portfolio expansion in Malaysia.
- Philips, Medtronic, and Abbott Japan are identified as key players in the Remote Patient Monitoring (RPM) market.
- Medtronic plans to integrate with Abbott’s Libre sensors as both firms develop multi-analyte sensor technology.
- Abbott Japan announces investments in new manufacturing and R&D facilities, coinciding with the availability of over-the-counter Continuous Glucose Monitoring (CGM).
- VIVO Agency, a strategic marketing partner for Medtech, lists Mayo Clinic and Abbott as clients.
- Abbott Japan and Agilent Technologies were identified as key players in the biochip market as of July 18, 2025.
- A report published in Austin, TX on July 23, 2025, identified Abbott Japan, COOK Trading, and Stryker as key players in the IVC Filter Market.
- Companies like Abbott, Danone, and Nestlé are leading the Homecare Clinical Nutrition Market, driven by aging populations.
- Abbott reported lower demand for commercial shipments in August 2025.
- Abbott sponsored a blood drive in Rosemont on August 18, 2025, in collaboration with the Big Ten Conference due to ongoing blood shortages.
- Abbott Japan, Danone, Fresenius Kabi, and Nestlé are competing for the leading position in a specific market.